Trypanosomes at the gates.
Cross
George A M
GA
D000818:Animals; D035843:Biomedical Research; D014355:Chagas Disease / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology; D003906:Developing Countries; D004345:Drug Industry; D018503:Genome, Protozoan; D006801:Humans; D018320:Leishmania major / Q000187:drug effects / Q000235:genetics* / Q000472:pathogenicity; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology; D011203:Poverty; D017422:Sequence Analysis, DNA; D014344:Trypanocidal Agents; D014346:Trypanosoma brucei brucei / Q000187:drug effects / Q000235:genetics* / Q000472:pathogenicity; D014349:Trypanosoma cruzi / Q000187:drug effects / Q000235:genetics* / Q000472:pathogenicity; D014353:Trypanosomiasis, African / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology
D014344:Trypanocidal Agents